FXH - First Trust Health Care AlphaDEX® Fund
| Previous Close | 70.62 |
| Open | 70.60 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 69.97 - 70.62 |
| 52 Week Range | 62.34 - 76.92 |
| Volume | 33,741 |
| Avg. Volume | 87,868 |
| Net Assets | 922.53M |
| NAV | 69.36 |
| PE Ratio (TTM) | N/A |
| Yield | 0.00% |
| YTD Return | -0.57% |
| Beta (3y) | 0.96 |
| Expense Ratio (net) | 0.62% |
| Inception Date | 2007-05-08 |
- Zacks•5 months ago
Looking to Buy The Dips? Here Are ETF & Stock Picks
We have highlighted five solid picks from both the ETF and the stock world that were in red over the past week but have a Zacks Rank #1 or 2.
- Business Wire•6 months ago
Four Additional First Trust ETFs Approved for Sale in Mexican Pension Plans
First Trust Advisors L.P. a global exchange-traded fund provider and asset manager, announced that the Mexican pension funds investment regulator, La Comisión Nacional del Sistema de Ahorro para el Retiro , has approved four additional First Trust ETFs for sale to Mexican funded pensions, known as AFORES.
- Market Realist•8 months ago
How United Therapeutics’ Remodulin and Tyvaso Are Performing
In 2Q17, United Therapeutics’ (UTHR) Remodulin generated revenues of around $158 million, which reflected ~8% growth on a quarter-over-quarter basis.
- Market Realist•9 months ago
Abiomed in 2017: The Analysts’ View
For the quarter ending March 31, 2017, Abiomed (ABMD) reported revenues close to $124.7 million, which represents a YoY growth of about 30%.
- Market Realist•10 months ago
Inside Align Technology’s Robust Revenue Growth Projection for 2017
For fiscal 2017, Align Technology (ALGN) expects its 2017 revenues to grow operationally in the range of 15%–25% YoY.
- Market Realist•11 months ago
WellCare Health Plans Expected to Report Solid Rise in EPS in 2017
WellCare Health Plans has updated its earnings per share guidance from the previously estimated range of $6.00–$6.25 to the new range of $6.55–$6.80.
- Market Realist•11 months ago
How Dentsply Sirona’s Profitability Metrics Looked in 1Q17
Dentsply Sirona’s (XRAY) 1Q17 earnings and revenue failed to meet analysts’ estimates. The company reported a fall in its organic revenue.
- Zacks•11 months ago
Sector ETFs to Win on Strong April Job Data
Bet on the ETFs of sectors that added solid jobs in the month of April and strengthened the month's data.
